Medtronic (MDT) r&d spend was $2.9B in FY2026 (+5% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2026
$2.9B
+5%
2025
$2.7B
-0%
2024
$2.7B
+1%
2023
$2.7B
-2%
2022
$2.7B
+10%
2021
$2.5B
+7%
2020
$2.3B
+0%
2019
$2.3B
+3%
2018
$2.3B
+3%
2017
$2.2B
-1%
2016
$2.2B
+36%
2015
$1.6B
+11%
2014
$1.5B
-5%
2013
$1.6B
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$771M
Q1 2026
$671M
Q3 2025
$754M
Q2 2025
$726M
Q1 2025
$684M
Q3 2024
$697M
Q2 2024
$676M
Q1 2024
$675M
Q3 2023
$698M
Q2 2023
$668M
Q1 2023
$641M
Q3 2022
$676M
Source: MDT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.